+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Impact of food on the pharmacokinetics and electrocardiographic effects of sustained release verapamil in normal subjects



Impact of food on the pharmacokinetics and electrocardiographic effects of sustained release verapamil in normal subjects



American Journal Of Cardiology. 70(11): 1072-1076



To evaluate the impact of food on the pharmacokinetics and electrocardiographic effects of sustained release (SR) verapamil tablets, 9 healthy men each received 3 single doses of verapamil in a randomized, crossover manner: 10 mg of intravenous verapamil, 240 mg SR verapamil on an empty stomach, and 240 mg SR verapamil with a standardized meal. PR intervals and racemic verapamil serum concentrations were measured serially over 30 hours after administration. The time to peak concentration was longer (7.5 +- 3.0 vs 4.4 +- 2.3 hours), resulting in a lower peak verapamil serum concentration (118 +- 43 vs 175 +- 50 ng/ml) when SR verapamil was administered with food (p lt 0.05). Food tended to decrease the bioavailability of SR verapamil (34 +- 12 vs 49 +- 14%), although this difference did not reach statistical significance (p = 0.065). Precipitous or exaggerated release of verapamil from the SR tablet was not observed in any subject during the fasting state. Prolongation of the PR interval paralleled these alterations in serum concentration. The maximal change in the PR interval was greater (21 +- 8 vs 14 +- 5%; p lt 0.05) when SR verapamil was given in the fasting state. Although an exaggerated verapamil release or effect was not observed, food significantly altered the absorption and electrocardiographic effects of a single dose of SR verapamil. Manipulation of the administration condition mey be helpful in achieving desired outcomes.

(PDF emailed within 0-6 h: $19.90)

Accession: 008826043

Download citation: RISBibTeXText

PMID: 1414906

DOI: 10.1016/0002-9149(92)90363-4


Related references

Evaluation of the pharmacokinetics and electrocardiographic effects of intravenous verapamil with intravenous calcium chloride pretreatment in normal subjects. American Journal of Cardiology 67(4): 300-304, 1991

Pharmacokinetics and dynamics of verapamil isomers following administration of immediate and sustained release racemic verapamil dosage forms. Clinical Pharmacology & Therapeutics 51(2): 153, 1992

Calcium antagonists and hormone release. VIII. Effects of verapamil infusion on C-peptide to insulin molar ratio in normal subjects and obese subjects with normal glucose tolerance. Diabetes Research 19(1): 9-16, 1992

Effects of food on the bioequivalence of different verapamil sustained-release formulations. Journal Of Clinical Pharmacology. 35(2): 163-169, 1995

Calcium antagonists and hormone release 1. effects of verapamil on insulin release in normal subjects and patients with islet cell tumor. Metabolism Clinical and Experimental 29(7): 599-604, 1980

Pharmacokinetic and electrocardiographic study of oral verapamil sustained-release tablet in 10 Chinese volunteers. Yaoxue Xuebao 31(7): 487-491, 1996

Pharmacokinetics of once-daily verapamil: comparative bioavailability of two sustained-release formulations. British Journal of Clinical Practice. Supplement 60: 14-19, 1988

Pharmacokinetics of verapamil and norverapamil enantiomers in humans following immediate- and sustained-release dosing. Pharmaceutical Research (New York) 10(10 SUPPL ): S319, 1993

Influence of time of dosing on the pharmacokinetics and pharmacodynamics of sustained release verapamil. British Journal of Clinical Pharmacology 25(1): 97P-98P, 1988

Pharmacokinetics of sustained-release verapamil after a single administration and at steady state. European Journal of Drug Metabolism and Pharmacokinetics 10(2): 133-138, 1985

Pharmacokinetics of verapamil and norverapamil in patients with hypertension a comparison of oral conventional and sustained release formulations. Pharmacology & Toxicology 63(2): 105-107, 1988

Comparison of the pharmacokinetics and electrocardiographic effects of sublingual and intravenous verapamil. PharmacoTherapy 12(1): 33-39, 1992

Effects of food intake on the pharmacokinetics, metabolism and urinary excretion of two sustained release theophylline preparations in nonanesthetized dogs. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 95(6): 361-368, 1990

Influence of food on the bioavailability of a sustained-release verapamil preparation. Journal of Pharmaceutical Sciences 79(3): 228-231, 1990

Effect of verapamil on peripheral chemosensitivity during sustained hypoxia in normal adult subjects. Japanese Journal of Physiology 41(SUPPL): S94, 1991